Company: MBIO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001104659-25-009408
Chunk: 256

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 256
---
 Wainwright & Co., LLC as an Agent. On April 14, 2023, the Mustang ATM was amended to add the limitations imposed by General Instruction I.B.6 to Form S-3 and remove Oppenheimer & Co., Inc. as an Agent. During the year ended December 31, 2023, the Company issued approximately 1,034 shares of common stock at an average price of $ 158.07 per share for gross proceeds of $ 163,000 under the ATM Agreement. In connection with these sales, the Company paid aggregate fees of approximately $ 3,000 for net proceeds of approximately $ 160,000 . During the year ended December 31, 2022, the Company issued approximately 10,504shares of common stock at an average price of $ 630.38per share for gross proceeds of $ 6.6million under the ATM Agreement. In connection with these sales, the Company paid aggregate fees of approximately $ 0.1million for net proceeds of approximately $ 6.5million. Pursuant to the Founders Agreement, the Company did not issue any shares of its common stock to Fortress for the year ended December 31, 2023, and recorded the value of 25 shares issuable to Fortress in connection with the Mustang ATM. Pursuant to the Founders Agreement, Mustang issued 259 shares of common stock to Fortress at a weighted average price of $ 634.49 per share for the year ended December 31, 2022, in connection with the Mustang ATM. Registered Direct Offering On October 26, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single institutional accredited investor (the “Investor”) pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Registered Offering”), (i) 18,400 shares of common stock, $ 0.0001 par value per share, at a price per Share of $ 85.00 and (ii) pre-funded warrants (the “Pre-funded Warrants”) to purchase up to 33,364 shares of its common stock, at a price per Pre-funded Warrant equal to $ 84.95 , the price per Share, less $ 0.05 . The Pre-funded Warrants have an exercise price of $ 0.05 per share, became exercisable upon issuance and remain exercisable until exercised